ADCs Are Not “Magic Bullets,” Says Paolo Tarantino - Binaytara / Binaytara, Breast Cancer, cancer, OncoDaily, Oncology, Paolo Tarantino

Binay Shah: Dr. Richard Maziarz On The Urgent Need For Innovative Models In Cellular Therapy Access / Binay Shah, Binaytara’s, cancer, OncoDaily, Oncology,

Dr. Mortuma Murry On Improving Transition From Pediatric To Adult Cancer Care - Binaytara / Binaytara, cancer, Mortuma Murry, OncoDaily, Oncology, Pediatric

Explore how SABCS 2025 innovations—risk-based screening, digital adherence tools, and survivorship platforms—are improving breast cancer care and equity in community oncology settings.

Binaytara Cancer Research Institute earns ASCO 2026 recognition for cervical cancer screening research in Nepal, advancing global implementation science and equitable cancer prevention.

Fred Hutchinson Cancer Center and UW Medicine took center stage at SCHD26, leading discussions on cancer disparities, clinical trial access, and equity in oncology care.

Dr. Srinivas Tantravahi Named 2026 Volunteer Of The Year - Binaytara / Binaytara, cancer, OncoDaily, Oncology, Srinivas Tantravahi

SABCS 2025 introduced major breast cancer advances, including earlier use of antibody–drug conjugates, oral SERDs for endocrine resistance, and mutation-guided therapy strategies shaping oncology…

Discover the leading oncologists and researchers serving on the Abstract and Scientific Review Committee for Binaytara’s 2026 Hematological Cancers Summit in Nashville.

Virginia Mason Franciscan Health experts led key sessions at SCHD26, driving innovation in patient navigation, chemotherapy education, and global cancer health equity.

Chinmay Jani: Grateful for a Wonderful Experience at the Binaytara Conference in Seattle / Adolescent and Young Adult (AYA), Binaytara conference, cancer,

Binaytara awarded $50,000 in research funding to early-career investigators through the new Impact Pitch competition at the 2026 Summit on Cancer Health Disparities.

A 15-year systematic review of cancer in Nepal reveals high late-stage diagnoses, financial hardship, and lack of national data—highlighting urgent needs for screening and policy reform.

Learn how liquid biopsy and multicancer early detection (MCED) blood tests work, what recent studies show about earlier cancer diagnosis, FDA-approved options, benefits, risks, and current…

IJCCD invites review articles on cancer care access, delivery challenges, and equity-focused solutions. Submit your manuscript to Binaytara’s open-access oncology journal with no publication fees.

Indigenous communities face disproportionately high rates of gallbladder and biliary cancers. Emerging research explores genetic risk, biological differences, and why tailored prevention strategies…

Over 100 SCHD26 abstracts are now published in IJCCD. Explore highlights from the six top oral presentations addressing cancer health disparities, AI innovation, genomics, and global equity.

Learn what metastatic (stage 4) cancer is, how cancer spreads through the lymphatic system and bloodstream, common metastatic sites, symptoms, diagnosis methods, and current treatment options.